Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury

Multiple Intestinal Bacteria Associated with the Better Protective Effect of Bifidobacterium pseudocatenulatum LI09 against Rat Liver Injury

(2022) Hua Zha et al.   Biomed Research International

Akkermansia muciniphila Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism

(2022) Jiafeng Xia et al.   Microbiology Spectrum

Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis

(2022) Linlin Wang et al.   Biomedicines

Fecal transplantation alleviates acute liver injury in mice through regulating Treg/Th17 cytokines balance

(2021) Yongmei Liu et al.   Scientific Reports

Fecal Microbiota Transplantation Is a Promising Method to Restore Gut Microbiota Dysbiosis and Relieve Neurological Deficits after Traumatic Brain Injury

(2021) Donglin Du et al.   Oxidative Medicine and Cellular Longevity

Immune surveillance by Myeloid derived suppressor cells (MDSCs) in liver diseases

(2021) Rashi Sehgal et al.   DIGESTIVE DISEASES

Probiotic Bacillus Spores Protect Against Acetaminophen Induced Acute Liver Injury in Rats

(2020) Maria Adriana Neag et al.   Nutrients

Bifidobacterium longum R0175 Protects Rats against D-Galactosamine-Induced Acute Liver Failure

(2020) Kaicen Wang et al.   mSphere

Intrahepatic TH17/TReg Cells in Homeostasis and Disease—It’s All About the Balance

(2020) Hannah K. Drescher et al.   Frontiers in Pharmacology

Antimicrobial and Immunomodulatory Effects of Bifidobacterium Strains: A Review

(2020) Hyun Jung Lim et al.   JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis

(2019) Nobuhiro Nakamoto et al.   Nature Microbiology

EASL Clinical Practice Guidelines: Drug-induced liver injury

(2019) Raúl Andrade et al.   JOURNAL OF HEPATOLOGY

Incidence and Etiology of Drug-Induced Liver Injury in Mainland China

(2019) Tao Shen et al.   GASTROENTEROLOGY

Dual effect of T helper cell 17 (Th17) and regulatory T cell (Treg) in liver pathological process: From occurrence to end stage of disease

(2019) Haoran Zhang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials

(2019) Hana Koutnikova et al.   BMJ Open

When worlds collide: Th17 and Treg cells in cancer and autoimmunity

(2018) Hannah M. Knochelmann et al.   Cellular & Molecular Immunology

Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice

(2018) Shenhai Gong et al.   JOURNAL OF HEPATOLOGY

The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression

(2018) Smruti Pushalkar et al.   Cancer Discovery

Investigating the CYP2E1 Potential Role in the Mechanisms Behind INH/LPS-Induced Hepatotoxicity

(2018) Hozeifa M. Hassan et al.   Frontiers in Pharmacology

Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats

(2018) Yating Li et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat

(2017) Lian Yee Yip et al.   HEPATOLOGY

CSH guidelines for the diagnosis and treatment of drug-induced liver injury

(2017) Yue-cheng Yu et al.   Hepatology International

Targeting the gut-liver axis in liver disease

(2017) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Mechanism of isoniazid-induced hepatotoxicity: then and now

(2016) Imir Metushi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Human SR-BI and SR-BII Potentiate Lipopolysaccharide-Induced Inflammation and Acute Liver and Kidney Injury in Mice

(2016) Irina N. Baranova et al.   JOURNAL OF IMMUNOLOGY

Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?

(2016) Liang Wen et al.   Oncotarget

Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity

(2015) Ru Chen et al.   ARCHIVES OF TOXICOLOGY

The Combination of Anti-CTLA-4 and PD1–/– Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury

(2015) Alastair Mak et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment

(2015) Mala Chakraborty et al.   HEPATOLOGY

Manipulating the Gut Microbiota: Methods and Challenges: Figure 1

(2015) Aaron C. Ericsson et al.   ILAR JOURNAL

Mild Isoniazid-Induced Liver Injury in Humans Is Associated with an Increase in Th17 Cells and T Cells Producing IL-10

(2014) Imir G. Metushi et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Mechanisms of isoniazid-induced idiosyncratic liver injury: Emerging role of mitochondrial stress

(2014) Urs A Boelsterli et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota

(2014) Jianing Chen et al.   Scientific Reports

Isoniazid-induced liver injury and immune response in mice

(2013) Imir G. Metushi et al.   Journal of Immunotoxicology

Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection

(2012) S. Fanning et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice

(2011) Felix Heymann et al.   HEPATOLOGY